123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Business >> View Article

Harver Group Releases Ipo Forecast For July 2013

Profile Picture
By Author: Harver Group
Total Articles: 26
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

Jul. 17, 2013 - CHUO-KU, Japan -- Peter Anderson, Senior Vice President of Mergers and Acquisitions at boutique equity research house Harver Group in Tokyo today approved the release of the company’s IPO forecast, written by the company’s head of investment analysis Mr. Nathan Marx and Director of Private Equity Mr. Stephen James. Below are a few of the picks detailed in the report.

NGR Yield is a power generation company, owning assets in conventional, renewable, and thermal power. They are hoping to generate $392 million by selling 19.6 million shares at a price range of $19.00 to $21.00. NRG Yield which was founded in 2012 recorded over $180 million in sales during the last twelve months. The company is based in Princeton, New Jersey and will be on the New York Stock Exchange under the symbol NYLD. Goldman Sachs, Citi, Merrill Lynch, and Bank of America. are the underwriters of the deal.

Rexford Industrial Reality is a real estate investment trust which owns and operates industrial properties in Southern California. They have filed a plan with US regulators to raise up to $300 million. They will be offering ...
... 16 million shares at a price range from $13 to $15. The company has recorded $35 million in sales during the last twelve months. The company is based in Los Angeles California and will be listed under the symbol REXR. Bank of America, Wells Fargo Securities, JP Morgan, and Merrill Lynch are the underwriters of the deal. Real estate investment trusts are particularly good for shareholders because they are required to distribute 90% of profits as dividends.

OncoMed Pharmaceuticals is a biotechnology company focusing on the improvement of cancer treatments by using monoclonal antibodies and other agents that target tumors initiating cells. They are planning to raise $60 million with an offering of 4 million shares at a price range of $14.00 to $16.00. OncoMed Pharmaceuticals recorded $25 million in sales during the last twelve months. The company was found in 2004 and is based in The Redwood City, California will be listed under the symbol OMED. Lee rink Swann and Jefferies & Co. are the underwriters of the deal.

Total Views: 200Word Count: 359See All articles From Author

Add Comment

Business Articles

1. Lucintel Forecasts The Global Agoraphobia Market To Reach $2 Billion By 2030
Author: Lucintel LLC

2. Lucintel Forecasts The Global Acute Care Hospital Bed And Stretcher Market To Reach $11 Billion By 2030
Author: Lucintel LLC

3. Lucintel Forecasts The Global Fibromuscular Dysplasia Treatment Market Is Expected To Grow With A Cagr Of 7.3% From 2024 To 2030
Author: Lucintel LLC

4. Elegant Glass Block Styles To Elevate Your Interior Decor
Author: ADVAN

5. Discover The Beauty Of Floating Stair Treads In Design
Author: ADVAN

6. Maximizing Bulk Sms Services Online
Author: Make My SMS

7. A Comparative Guide For Front-end Development: Angularjs Vs Reactjs
Author: Alena Mage

8. 7 Ways To Find New Donors: Tips For New Nonprofits
Author: Yash

9. Convenient And Reliable Taxi Service In Denver: Serving Thornton And Longmont
Author: Rebecca Jones

10. Sustainability Meets Tech - Eco-friendly Solutions In Modern Interior Design
Author: Alaikha

11. A Brief Guide To Stainless Steel Round Bars
Author: Neelkamal Alloys LLP

12. Digital Marketing And Freelancing: The Perfect Match For The Modern Workforce
Author: shahla

13. Upgrade Your Financial Infrastructure: The Key Role Of An Accounting Data Migration Agency
Author: admin

14. Union Tee Manufacturers In India
Author: Vivek Shah

15. How To Remove Black Magic From Your Home
Author: Shardanand Shastri

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: